stockrowDoximity, Inc.
DOCS Healthcare Health Information Services
Doximity, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $644.9 million, up 13.1% from fiscal 2025.
- Revenue
- +3.57%
- EPS
- −42.4%
- Free cash flow
- +1.87%
Quarter to September 2026, against a year earlier
Follow DOCS
Alert me
Doximity, Inc. (DOCS) Free cash flow margin
Doximity, Inc.'s free cash flow margin over the twelve months to 30 September 2026 was 46.2%, down 3.0 percentage points from fiscal 2026 (49.2%). Over the past ten years it has ranged from 16.5% (fiscal 2019) to 49.2% (fiscal 2026) — the current reading is the highest in ten years. That is above the Health Information Services industry median of 0.00% and above the Healthcare sector median of 0.00%.
Free cash flow margin, annual
Embed this chart
Annual newest first
| Period | Free cash flow margin | Change (points) |
|---|---|---|
| FY2026 | 49.2% | 2.47 |
| FY2025 | 46.8% | 9.26 |
| FY2024 | 37.5% | (3.88) |
| FY2023 | 41.4% | 6.19 |
| FY2022 | 35.2% | (2.69) |
| FY2021 | 37.9% | 19.02 |
| FY2020 | 18.9% | 2.39 |
| FY2019 | 16.5% | — |
Against its own ten years
Free cash flow margin against peers
| Company | Free cash flow margin |
|---|---|
| DOCS Doximity, Inc. | 46.2% |
| HNGE Hinge Health Inc. compare | 39.4% |
| HQY HealthEquity, Inc. compare | 32.1% |
| WAY Waystar Holding Corp. compare | 20.9% |
| PRVA Privia Health Group, Inc. compare | 4.44% |
| BTSG BrightSpring Health Services, Inc. compare | 3.23% |
| TEM Tempus AI, Inc. compare | −9.98% |
| HTFL Heartflow, Inc. compare | −27.9% |
| SDGR Schrodinger, Inc. compare | −43.4% |
| Health Information Services industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Free cash flow margin is
Free Cash Flow Margin tells an investor how much of each sale turns into cash the company keeps after paying for investment in its assets.
(Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)) ÷ Revenue
More on DOCS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement